 CEA (5.2%) vs CAS (8.5%; P < .006). These ﬁndings
were similar to those for the symptomatic patients
enrolled in the CREST (carotid revascularization endarterectomy vs stenting trial).9 In the CREST, the periprocedural rate of stroke and death was signiﬁcantly greater
after TF-CAS than after CEA for symptomatic patients
(6.0%